Co-Authors
This is a "connection" page, showing publications co-authored by DAN S GOMBOS and SAPNA PRADYUMAN PATEL.
Connection Strength
1.026
-
Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients. Cancers (Basel). 2021 Jun 30; 13(13).
Score: 0.206
-
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. J Immunother Cancer. 2020 11; 8(2).
Score: 0.197
-
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study. J Clin Oncol. 2021 02 20; 39(6):599-607.
Score: 0.197
-
Adjuvant Ipilimumab in High-Risk Uveal Melanoma. Cancers (Basel). 2019 Jan 29; 11(2).
Score: 0.174
-
Uveal melanoma: From diagnosis to treatment and the science in between. Cancer. 2016 08 01; 122(15):2299-312.
Score: 0.143
-
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma. J Immunother. 2018 Nov/Dec; 41(9):399-405.
Score: 0.043
-
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study. Oncoimmunology. 2017; 6(6):e1321187.
Score: 0.039
-
Surveillance options for patients with uveal melanoma following definitive management. Am Soc Clin Oncol Educ Book. 2013; 382-7.
Score: 0.029